BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 250 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $46,001,000 | +1531.8% | 304,300 | +1472.9% | 0.14% | +1650.0% |
| Q2 2022 | $2,819,000 | +767.4% | 19,346 | +720.8% | 0.01% | +700.0% |
| Q4 2021 | $325,000 | +37.7% | 2,357 | +38.6% | 0.00% | 0.0% |
| Q3 2021 | $236,000 | +10.8% | 1,700 | -22.7% | 0.00% | 0.0% |
| Q2 2021 | $213,000 | -20.8% | 2,200 | -30.1% | 0.00% | 0.0% |
| Q4 2020 | $269,000 | -64.2% | 3,146 | -77.2% | 0.00% | -80.0% |
| Q4 2019 | $751,000 | -54.4% | 13,800 | -65.1% | 0.01% | -64.3% |
| Q3 2019 | $1,648,000 | -56.0% | 39,500 | -53.8% | 0.01% | -56.2% |
| Q2 2019 | $3,747,000 | +60.9% | 85,581 | +89.2% | 0.03% | +77.8% |
| Q1 2019 | $2,329,000 | -8.1% | 45,232 | -34.0% | 0.02% | -5.3% |
| Q4 2018 | $2,533,000 | – | 68,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |